Kinnate Biopharma
(NASDAQ:KNTE)
$2.65
-0.01[-0.38%]
Last update: 6:30PM Get Real Time Here
37.5%
Overview Rating
Speculative
Technicals Analysis
33
0100
Financials Analysis
40
0100

Kinnate Biopharma Stock (NASDAQ:KNTE), Quotes and News Summary

Kinnate Biopharma Stock (NASDAQ: KNTE) stock price, news, charts, stock research, profile.

Open$2.660
Close-
Volume / Avg.38.211K / 374.369K
Day Range2.660 - 2.690
52 Wk Range1.040 - 7.185
Market Cap$124.991M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
67
Short Interest
3.6%
Days to Cover8.64
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
0
0
0
0
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Kinnate Biopharma Inc
Sector
Health Care
Industry
Biotechnology
Kinnate Biopharma Inc is a clinical-stage precision oncology company focused on the discovery, desig...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
KNTE
MOLN

FAQ

Q

How do I buy Kinnate Biopharma (KNTE) stock?

A

You can purchase shares of Kinnate Biopharma (NASDAQ: KNTE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kinnate Biopharma's (KNTE) competitors?

Q

What is the target price for Kinnate Biopharma (KNTE) stock?

A

The latest price target for Kinnate Biopharma (NASDAQ: KNTE) was reported by Stifel on Monday, February 26, 2024. The analyst firm set a price target for 2.59 expecting KNTE to fall to within 12 months (a possible -3.36% downside). 14 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kinnate Biopharma (KNTE)?

A

The stock price for Kinnate Biopharma (NASDAQ: KNTE) is $2.68 last updated Today at March 28, 2024 at 11:06 AM EDT.

Q

Does Kinnate Biopharma (KNTE) pay a dividend?

A

There are no upcoming dividends for Kinnate Biopharma.

Q

When is Kinnate Biopharma (NASDAQ:KNTE) reporting earnings?

A

Kinnate Biopharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Kinnate Biopharma (KNTE) going to split?

A

There is no upcoming split for Kinnate Biopharma.

Q

What sector and industry does Kinnate Biopharma (KNTE) operate in?

A

Kinnate Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch